Sentinel May Expand To Generic Equivalence Studies

The US FDA's Sentinel system eventually may grow to help assess generic drug equivalence and improve its ability to find safety problems.

Sentinel has commissioned researchers to develop a tool to characterize product utilization and switching patterns, including between brand drugs and generics. The tool will capture switching at the manufacturer level...